Comparison of the impact of the type of medicinal treatment on the quality of life of patients with rheumatoid arthritis in a regional health of Bahia
International Journal of Development Research
Comparison of the impact of the type of medicinal treatment on the quality of life of patients with rheumatoid arthritis in a regional health of Bahia
Received 03rd February, 2019; Received in revised form 16th March, 2019; Accepted 26th April, 2019; Published online 30th May, 2019
Copyright © 2019, Thalita Souza Mendonça et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective: compare the impact of the type of drug treatment on quality of life of patients with rheumatoid arthritis. Methods: A cross-sectional descriptive study was performed with a sample of 100 patients. The instruments applied include Short Form (SF-6), Stanford Health Assessment Questionnaire (HAQ) and visual analogue scale (EVA). Data analysis was done by descriptive statistics, the respective means ± standard deviation were calculated, considering Student's T-Test, ANOVA test and Chi-square test, and a significance level of p <0.05 was adopted. Results: On the HAQ scale, individuals who used biological drugs had a higher prevalence in the category of severe deficiency (22.2%), individuals who used synthetic drugs had a higher percentage in the category of moderate deficiency (53.1%) and control group presented a prevalence in the category of mild deficiency (91.7%). Through the results of the Sf-6 and EVA scales, the quality of life was also more affected in patients with RA, however the difference in the type of drug treatment was not significant in any of the results. Conclusion: The results of the study showed that quality of life is impaired in patients with rheumatoid arthritis regardless of the type of drug treatment.
